[1]
L. T. K. Tam and N. T. T. Hoa, “Comment on primary effectiveness of rituximab plus chemotherapy in treating CD 20 + non hodgkin lymphoma”, JCMHCH, vol. 5, no. 17, pp. 191–195, Feb. 2025.